Rituximab is an antibody-based therapy that may be used off-label in patients with certain types of myasthenia gravis.| Myasthenia Gravis News
Joana Carvalho is a managing science editor for BioNews with a PhD in biomedical sciences. She edits and fact-checks articles on a variety of rare and chronic disease topics.| Myasthenia Gravis News
Intravenous immunoglobulin (IVIG) is a compound that consists of immune globulins (immune proteins) that are usually administered into the bloodstream, to treat patients with severe or worsening myasthenia gravis.| Myasthenia Gravis News
Muscle weakness and fatigue are hallmark symptoms of myasthenia gravis (MG), an autoimmune disorder. MG symptoms may come and go.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Plasmapheresis is a treatment for myasthenia gravis, commonly used during a myasthenic crisis and in preparation for thymectomy.| Myasthenia Gravis News
Generalized myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness in different parts of the body.| Myasthenia Gravis News
